These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6859963)

  • 1. A new specific assay for the detection of DNA immune complexes: its relevance in SLE.
    Klemp P; Meyers OL; Harley EH
    Ann Rheum Dis; 1983 Jun; 42(3):317-22. PubMed ID: 6859963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune complexes, complement, and anti-DNA in exacerbations of systemic lupus erythematosus (SLE).
    Lloyd W; Schur PH
    Medicine (Baltimore); 1981 May; 60(3):208-17. PubMed ID: 7231154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between anti-DNA antibodies complement consumption and circulating immune complexes in systemic lupus erythematosus.
    Davis P; Cumming RH; Verrier-Jones J
    Clin Exp Immunol; 1977 May; 28(2):226-32. PubMed ID: 301447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A longitudinal study of circulating immune complexes, dna antibodies and complement in patients with systemic lupus erythematosus: an analysis of their relationship to disease activity.
    Harkiss GD; Hazleman BL; Brown DL
    J Clin Lab Immunol; 1979 Nov; 2(4):275-83. PubMed ID: 537024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A longitudinal study of high and low avidity antibodies to double-stranded DNA in systemic lupus erythematosus.
    McGrath H; Biundo JJ
    Arthritis Rheum; 1985 Apr; 28(4):425-30. PubMed ID: 3885960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct stimulation of neutrophil oxygenation activity by serum from patients with systemic lupus erythematosus: a relationship to disease activity.
    Via CS; Allen RC; Welton RC
    J Rheumatol; 1984 Dec; 11(6):745-53. PubMed ID: 6520828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation and predictive accuracy of circulating immune complexes with disease activity in patients with systemic lupus erythematosus.
    Abrass CK; Nies KM; Louie JS; Border WA; Glassock RJ
    Arthritis Rheum; 1980 Mar; 23(3):273-82. PubMed ID: 6987992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Useful laboratory measurements in the management of systemic lupus erythematosus.
    Morrow WJ; Isenberg DA; Todd-Pokropek A; Parry HF; Snaith ML
    Q J Med; 1982; 51(202):125-38. PubMed ID: 6981121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical studies on the significance of DNA:anti-DNA complexes in the systemic circulation and cerebrospinal fluid (CSF) of patients with systemic lupus erythematosus.
    Carr RI; Harbeck RJ; Hoffman AA; Pirofsky B; Bardana EJ
    J Rheumatol; 1975 Jun; 2(2):184-93. PubMed ID: 807729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibodies associated with RNA are more enriched than anti-dsDNA antibodies in circulating immune complexes in SLE.
    Ahlin E; Mathsson L; Eloranta ML; Jonsdottir T; Gunnarsson I; Rönnblom L; Rönnelid J
    Lupus; 2012 May; 21(6):586-95. PubMed ID: 22300829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic and therapeutic implications of DNA:anti-DNA immune complexes in systemic lupus erythematosus (SLE).
    Bardana EJ; Harbeck RJ; Hoffman AA; Pirofsky B; Carr RI
    Am J Med; 1975 Oct; 59(4):515-22. PubMed ID: 1166858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific detection of circulating DNA:anti-DNA immune complexes in human systemic lupus erythematosus sera using murine monoclonal anti-DNA antibody.
    Tron F; Letarte J; Roque-Antunes Barreira MC; Lesavre P
    Clin Exp Immunol; 1982 Aug; 49(2):481-7. PubMed ID: 6982138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement-mediated solubilization of immune complexes in systemic lupus erythematosus.
    Sakurai T; Fujita T; Kono I; Kabashima T; Yamane K; Tamura N; Kashiwagi H
    Clin Exp Immunol; 1982 Apr; 48(1):37-42. PubMed ID: 6979449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mononuclear phagocyte system in SLE. II. A kinetic model of immune complex handling in systemic lupus erythematosus.
    Meryhew NL; Kimberly RP; Messner RP; Runquist OA
    J Immunol; 1986 Jul; 137(1):97-102. PubMed ID: 3486919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypercatabolism of C3 and C4 in active and inactive systemic lupus erythematosus.
    Charlesworth JA; Peake PW; Golding J; Mackie JD; Pussell BA; Timmermans V; Wakefield D
    Ann Rheum Dis; 1989 Feb; 48(2):153-9. PubMed ID: 2784659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A specific DNA immune complex assay, and its application in SLE.
    Harley EH; Klemp P
    Clin Chim Acta; 1982 Jul; 122(2):213-23. PubMed ID: 7105408
    [No Abstract]   [Full Text] [Related]  

  • 17. DNA-anti-DNA complexes account for part of the antihistone activity found in patients with systemic lupus erythematosus.
    Subiza JL; Caturla A; Pascual-Salcedo D; Chamorro MJ; Gazapo E; Figueredo MA; de la Concha EG
    Arthritis Rheum; 1989 Apr; 32(4):406-12. PubMed ID: 2706026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features of systemic lupus erythematosus patients with antihistone antibodies.
    Fritzler M; Ryan P; Kinsella TD
    J Rheumatol; 1982; 9(1):46-51. PubMed ID: 7086779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic lupus erythematosus glomerulonephritis in children.
    Garin EH; Shulman ST; Donnelly WH; Richard GA
    Paediatrician; 1981; 10(5-6):351-67. PubMed ID: 6460214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection and characterization of DNA-anti-DNA complexes in a patient with systemic lupus erythematosus.
    Bruneau CD; Edmonds JP; Hughes GR; Aarden L
    Clin Exp Immunol; 1977 Jun; 28(3):433-6. PubMed ID: 302166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.